Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial

AIMS: Diabetes mellitus (DM) is common in heart failure with preserved ejection fraction (HFpEF). Patients with DM and heart failure with reduced ejection fraction have higher levels of cardiac, profibrotic, and proinflammatory biomarkers relative to non‐diabetics. Limited data are available regardi...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marco, Corrado, Claggett, Brian L., de Denus, Simon, Zile, Michael R., Huynh, Thao, Desai, Akshay S., Sirois, Martin G., Solomon, Scott D., Pitt, Bertram, Rouleau, Jean L., Pfeffer, Marc A., O'Meara, Eileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006665/
https://www.ncbi.nlm.nih.gov/pubmed/33438360
http://dx.doi.org/10.1002/ehf2.13153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006665/
https://www.ncbi.nlm.nih.gov/pubmed/33438360
http://dx.doi.org/10.1002/ehf2.13153

Ejemplares similares